{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:14:10Z","timestamp":1793315650192,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273380"],"award-info":[{"award-number":["82273380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472375"],"award-info":[{"award-number":["82472375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273418"],"award-info":[{"award-number":["82273418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,3,3]]},"DOI":"10.1038\/s41388-026-03687-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:15:22Z","timestamp":1770020122000},"page":"728-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["POM121 O-GlcNAcylation facilitates bone metastasis in non-small cell lung cancer through enhanced c-MYC nuclear import and ECM reprogramming"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-6430","authenticated-orcid":false,"given":"Yi-Zhe","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8373-7267","authenticated-orcid":false,"given":"Ming-Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Lin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-3255","authenticated-orcid":false,"given":"Jia-Tao","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr., Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299\u2013311.","journal-title":"Lancet"},{"key":"3687_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584\u201394.","journal-title":"Mayo Clin Proc"},{"key":"3687_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihim\u00e4ki","year":"2014","unstructured":"Riihim\u00e4ki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86:78\u201384.","journal-title":"Lung Cancer"},{"key":"3687_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.21037\/tlcr-20-835","volume":"10","author":"S Wu","year":"2021","unstructured":"Wu S, Pan Y, Mao Y, Chen Y, He Y. Current progress and mechanisms of bone metastasis in lung cancer: a narrative review. Transl Lung Cancer Res. 2021;10:439\u201351.","journal-title":"Transl Lung Cancer Res"},{"key":"3687_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1164\/rccm.201503-0440SO","volume":"192","author":"S Vicent","year":"2015","unstructured":"Vicent S, Perurena N, Govindan R, Lecanda F. Bone metastases in lung cancer. Potential novel approaches to therapy. Am J Respir Crit Care Med. 2015;192:799\u2013809.","journal-title":"Am J Respir Crit Care Med"},{"key":"3687_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1493773","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, She J, Sun R, Yan X, Huang X, Wang P, et al. Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Immunol. 2024;15:1493773.","journal-title":"Front Immunol"},{"key":"3687_CR7","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.7150\/ijbs.100960","volume":"20","author":"M Xue","year":"2024","unstructured":"Xue M, Ma L, Zhang P, Yang H, Wang Z. New insights into non-small cell lung cancer bone metastasis: mechanisms and therapies. Int J Biol Sci. 2024;20:5747\u201363.","journal-title":"Int J Biol Sci"},{"key":"3687_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10555-007-9081-z","volume":"26","author":"S Sone","year":"2007","unstructured":"Sone S, Yano S. Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev. 2007;26:685\u20139.","journal-title":"Cancer Metastasis Rev"},{"key":"3687_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med. 2022;86:101097.","journal-title":"Mol Aspects Med"},{"key":"3687_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang X, Qian K. Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol. 2017;18:452\u201365.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3687_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1152\/physrev.00043.2019","volume":"101","author":"JC Chatham","year":"2021","unstructured":"Chatham JC, Zhang J, Wende AR. Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology. Physiol Rev. 2021;101:427\u201393.","journal-title":"Physiol Rev"},{"key":"3687_CR12","doi-asserted-by":"publisher","first-page":"12918","DOI":"10.1021\/acs.chemrev.4c00417","volume":"124","author":"SS Cheng","year":"2024","unstructured":"Cheng SS, Mody AC, Woo CM. Opportunities for Therapeutic Modulation of O-GlcNAc. Chem Rev. 2024;124:12918\u20133019.","journal-title":"Chem Rev"},{"key":"3687_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217101","volume":"598","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li R, Wang W, Zhang H, Zhang Q, Jiang J, et al. O-GlcNAc signaling: Implications for stress-induced adaptive response pathway in the tumor microenvironment. Cancer Lett. 2024;598:217101.","journal-title":"Cancer Lett"},{"key":"3687_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg7112","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yu K, Kong X, Zhang K, Wang L, Zhang N, et al. FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer. Sci Adv. 2023;9:eadg7112.","journal-title":"Sci Adv"},{"key":"3687_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40:1207\u201322.e10.","journal-title":"Cancer Cell"},{"key":"3687_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrm.2016.147","volume":"18","author":"M Beck","year":"2017","unstructured":"Beck M, Hurt E. The nuclear pore complex: understanding its function through structural insight. Nat Rev Mol Cell Biol. 2017;18:73\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3687_CR17","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.cell.2016.01.034","volume":"164","author":"KE Knockenhauer","year":"2016","unstructured":"Knockenhauer KE, Schwartz TU. The Nuclear Pore Complex as a Flexible and Dynamic Gate. Cell. 2016;164:1162\u201371.","journal-title":"Cell"},{"key":"3687_CR18","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1091\/mbc.e10-07-0641","volume":"22","author":"T Funakoshi","year":"2011","unstructured":"Funakoshi T, Clever M, Watanabe A, Imamoto N. Localization of Pom121 to the inner nuclear membrane is required for an early step of interphase nuclear pore complex assembly. Mol Biol Cell. 2011;22:1058\u201369.","journal-title":"Mol Biol Cell"},{"key":"3687_CR19","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/j.febslet.2010.07.008","volume":"584","author":"S Yavuz","year":"2010","unstructured":"Yavuz S, Santarella-Mellwig R, Koch B, Jaedicke A, Mattaj IW, Antonin W. NLS-mediated NPC functions of the nucleoporin Pom121. FEBS Lett. 2010;584:3292\u20138.","journal-title":"FEBS Lett"},{"key":"3687_CR20","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, et al. H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. Cancer Res. 2024;84:3589\u2013601.","journal-title":"Cancer Res"},{"key":"3687_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cord\u00f3n-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537\u201349.","journal-title":"Cancer Cell"},{"key":"3687_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10585-011-9409-5","volume":"28","author":"D Luis-Ravelo","year":"2011","unstructured":"Luis-Ravelo D, Ant\u00f3n I, Vicent S, Hern\u00e1ndez I, Valencia K, Zandueta C, et al. Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models. Clin Exp Metastasis. 2011;28:779\u201391.","journal-title":"Clin Exp Metastasis"},{"key":"3687_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05819-8","volume":"14","author":"M-N Zhao","year":"2023","unstructured":"Zhao M-N, Zhang L-F, Sun Z, Qiao L-H, Yang T, Ren Y-Z, et al. A novel microRNA-182\/Interleukin-8 regulatory axis controls osteolytic bone metastasis of lung cancer. Cell Death Dis. 2023;14:298.","journal-title":"Cell Death Dis"},{"key":"3687_CR24","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367\u201372.","journal-title":"Nat Biotechnol"},{"key":"3687_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357\u201360.","journal-title":"Nat Methods"},{"key":"3687_CR26","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3687_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216742","volume":"588","author":"L Chen","year":"2024","unstructured":"Chen L, Hu M, Chen L, Peng Y, Zhang C, Wang X, et al. Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues. Cancer Lett. 2024;588:216742.","journal-title":"Cancer Lett"},{"key":"3687_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216258","volume":"566","author":"X-F He","year":"2023","unstructured":"He X-F, Hu X, Wen G-J, Wang Z, Lin W-J. O-GlcNAcylation in cancer development and immunotherapy. Cancer Lett. 2023;566:216258.","journal-title":"Cancer Lett"},{"key":"3687_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.456","volume":"4","author":"L Ye","year":"2023","unstructured":"Ye L, Ding W, Xiao D, Jia Y, Zhao Z, Ao X, et al. O-GlcNAcylation: cellular physiology and therapeutic target for human diseases. MedComm (2020). 2023;4:e456.","journal-title":"MedComm (2020)"},{"key":"3687_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01932-0","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qin C, Dewanjee S, Bhattacharya H, Chakraborty P, Jha NK, et al. Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. Mol Cancer. 2024;23:18.","journal-title":"Mol Cancer"},{"key":"3687_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets. Sci Transl Med. 2024;16:eadg3840.","journal-title":"Sci Transl Med"},{"key":"3687_CR32","first-page":"1387","volume":"8","author":"R Harisi","year":"2015","unstructured":"Harisi R, Jeney A. Extracellular matrix as target for antitumor therapy. Onco Targets Ther. 2015;8:1387\u201398.","journal-title":"Onco Targets Ther"},{"key":"3687_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53849-3","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Xiao K, Wen Y, Wu F, Gao G, Chen L, et al. Multi-omics with dynamic network biomarker algorithm prefigures organ-specific metastasis of lung adenocarcinoma. Nat Commun. 2024;15:9855.","journal-title":"Nat Commun"},{"key":"3687_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217153","volume":"600","author":"L Huang","year":"2024","unstructured":"Huang L, Liu X, Chen Q, Yang J, Zhang D, Zhao Y, et al. TGF-\u03b2-induced lncRNA TBUR1 promotes EMT and metastasis in lung adenocarcinoma via hnRNPC-mediated GRB2 mRNA stabilization. Cancer Lett. 2024;600:217153.","journal-title":"Cancer Lett"},{"key":"3687_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101150","volume":"77","author":"X Zeng","year":"2024","unstructured":"Zeng X, Chen Z, Zhu Y, Liu L, Zhang Z, Xiao Y, et al. O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma. Drug Resist Updat. 2024;77:101150.","journal-title":"Drug Resist Updat"},{"key":"3687_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70037","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Sun C, Ma L, Xiao G, Gu Y, Yu W. O-GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2. Clin Transl Med. 2024;14:e70037.","journal-title":"Clin Transl Med"},{"key":"3687_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216796120","volume":"120","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Wang H, Chai S, Xu L, Lin B, Yi W, et al. O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation. Proc Natl Acad Sci USA. 2023;120:e2216796120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3687_CR38","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41418-022-00984-3","volume":"29","author":"X He","year":"2022","unstructured":"He X, Li Y, Chen Q, Zheng L, Lou J, Lin C, et al. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REG\u03b3 interaction. Cell Death Differ. 2022;29:1970\u201381.","journal-title":"Cell Death Differ"},{"key":"3687_CR39","doi-asserted-by":"publisher","first-page":"e144703.","DOI":"10.1172\/JCI144703","volume":"131","author":"J Xiang","year":"2021","unstructured":"Xiang J, Chen C, Liu R, Gou D, Chang L, Deng H, et al. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. J Clin Invest. 2021;131:e144703.","journal-title":"J Clin Invest"},{"key":"3687_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.physiol.60.1.575","volume":"60","author":"EB Thompson","year":"1998","unstructured":"Thompson EB. The many roles of c-Myc in apoptosis. Annu Rev Physiol. 1998;60:575\u2013600.","journal-title":"Annu Rev Physiol"},{"key":"3687_CR41","doi-asserted-by":"crossref","unstructured":"Farrell AS, Sears RC. MYC degradation. Cold Spring Harb Perspect Med. 2014; 4.","DOI":"10.1101\/cshperspect.a014365"},{"key":"3687_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tcb.2022.07.006","volume":"33","author":"SK Das","year":"2023","unstructured":"Das SK, Lewis BA, Levens D. MYC: a complex problem. Trends Cell Biol. 2023;33:235\u201346.","journal-title":"Trends Cell Biol"},{"key":"3687_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-020-0215-2","volume":"21","author":"A Baluapuri","year":"2020","unstructured":"Baluapuri A, Wolf E, Eilers M. Target gene-independent functions of MYC oncoproteins. Nat Rev Mol Cell Biol. 2020;21:255\u201367.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3687_CR44","doi-asserted-by":"publisher","first-page":"a014373","DOI":"10.1101\/cshperspect.a014373","volume":"4","author":"A Kuzyk","year":"2014","unstructured":"Kuzyk A, Mai S. c-MYC-induced genomic instability. Cold Spring Harb Perspect Med. 2014;4:a014373.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3687_CR45","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","volume":"1849","author":"G Bretones","year":"2015","unstructured":"Bretones G, Delgado MD, Le\u00f3n J. Myc and cell cycle control. Biochim Biophys Acta. 2015;1849:506\u201316.","journal-title":"Biochim Biophys Acta"},{"key":"3687_CR46","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1158\/0008-5472.CAN-09-3556","volume":"70","author":"CV Dang","year":"2010","unstructured":"Dang CV. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 2010;70:859\u201362.","journal-title":"Cancer Res"},{"key":"3687_CR47","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","volume":"83","author":"H Fatma","year":"2022","unstructured":"Fatma H, Maurya SK, Siddique HR. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance. Semin Cancer Biol. 2022;83:166\u201376.","journal-title":"Semin Cancer Biol"},{"key":"3687_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"key":"3687_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"M-Z Jin","year":"2020","unstructured":"Jin M-Z, Jin W-L. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5:166.","journal-title":"Signal Transduct Target Ther"},{"key":"3687_CR50","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. Mol Cell. 2020;78:1019\u201333.","journal-title":"Mol Cell"},{"key":"3687_CR51","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm.4400","volume":"23","author":"M Murgai","year":"2017","unstructured":"Murgai M, Ju W, Eason M, Kline J, Beury DW, Kaczanowska S, et al. KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis. Nat Med. 2017;23:1176\u201390.","journal-title":"Nat Med"},{"key":"3687_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32255-7","volume":"13","author":"M Papanicolaou","year":"2022","unstructured":"Papanicolaou M, Parker AL, Yam M, Filipe EC, Wu SZ, Chitty JL, et al. Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat Commun. 2022;13:4587.","journal-title":"Nat Commun"},{"key":"3687_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrc3726","volume":"14","author":"DM Gilkes","year":"2014","unstructured":"Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14:430\u20139.","journal-title":"Nat Rev Cancer"},{"key":"3687_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/CBM-210001","volume":"32","author":"L Guan","year":"2021","unstructured":"Guan L, Zhang L, Wang T, Jia L, Zhang N, Yan H, et al. POM121 promotes proliferation and metastasis in non-small-cell lung cancer through TGF-\u03b2\/SMAD and PI3K\/AKT pathways. Cancer Biomark. 2021;32:293\u2013302.","journal-title":"Cancer Biomark"},{"key":"3687_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14737159.2020.1707670","volume":"20","author":"T Wang","year":"2019","unstructured":"Wang T, Sun H, Bao Y, En R, Tian Y, Zhao W, et al. POM121 overexpression is related to a poor prognosis in colorectal cancer. Expert Rev Mol Diagn. 2019;20:345\u201353.","journal-title":"Expert Rev Mol Diagn"},{"key":"3687_CR56","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1158\/1078-0432.CCR-18-3442","volume":"25","author":"R Zhou","year":"2019","unstructured":"Zhou R, Shi C, Tao W, Li J, Wu J, Han Y, et al. Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations. Clin Cancer Res. 2019;25:3548\u201360.","journal-title":"Clin Cancer Res"},{"key":"3687_CR57","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","volume":"174","author":"DA Quigley","year":"2018","unstructured":"Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, et al. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018;174:758\u201369.e9.","journal-title":"Cell"},{"key":"3687_CR58","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/S1470-2045(22)00633-7","volume":"24","author":"S Chatterji","year":"2023","unstructured":"Chatterji S, Krzoska E, Thoroughgood CW, Saganty J, Liu P, Elsberger B, et al. Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review. Lancet Oncol. 2023;24:e74\u2013e85.","journal-title":"Lancet Oncol"},{"key":"3687_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coche.2016.01.001","volume":"11","author":"LE Barney","year":"2016","unstructured":"Barney LE, Jansen LE, Polio SR, Galarza S, Lynch ME, Peyton SR. The Predictive Link between Matrix and Metastasis. Curr Opin Chem Eng. 2016;11:85\u201393.","journal-title":"Curr Opin Chem Eng"},{"key":"3687_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021;6:153.","journal-title":"Signal Transduct Target Ther"},{"key":"3687_CR61","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/gutjnl-2022-327913","volume":"72","author":"X Li","year":"2022","unstructured":"Li X, Pan J, Liu T, Yin W, Miao Q, Zhao Z, et al. Novel TCF21high pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix. Gut. 2022;72:710\u201321.","journal-title":"Gut"},{"key":"3687_CR62","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.15252\/emmm.201404827","volume":"7","author":"BW Miller","year":"2015","unstructured":"Miller BW, Morton JP, Pinese M, Saturno G, Jamieson NB, McGhee E, et al. Targeting the LOX\/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Mol Med. 2015;7:1063\u201376.","journal-title":"EMBO Mol Med"},{"key":"3687_CR63","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s41418-023-01160-x","volume":"30","author":"K Yang","year":"2023","unstructured":"Yang K, Zhang W, Zhong L, Xiao Y, Sahoo S, Fassan M, et al. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. Cell Death Differ. 2023;30:1533\u201349.","journal-title":"Cell Death Differ"},{"key":"3687_CR64","doi-asserted-by":"publisher","first-page":"qzaf072.","DOI":"10.1093\/gpbjnl\/qzaf072","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, Chen X, Jin E, Wang A, Chen T, Zhang X, et al. The GSA Family in 2025: A Broadened Sharing Platform for Multi-omics and Multimodal Data. Genomics Proteomics Bioinformatics. 2025;23:qzaf072.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"3687_CR65","unstructured":"Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Res. 2025;53:D30-D44."}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03687-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03687-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03687-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:02:11Z","timestamp":1770678131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03687-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,3,3]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03687-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}